Cargando…
Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
From December 2019 to May 22, 2020 the emerging and ever-increasing pandemic of coronavirus 19 (COVID-19) had no effective and safe treatment. Not surprisingly, remdesivir attracted worldwide attention. In a trial published online ahead of print, of 1063 patients, 541 were assigned at random to remd...
Autores principales: | Shih, Richard D., Maki, Dennis G., Hennekens, Charles H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538864/ https://www.ncbi.nlm.nih.gov/pubmed/33043163 http://dx.doi.org/10.1016/j.conctc.2020.100663 |
Ejemplares similares
-
Remdesivir retreatment: another unproven intervention for COVID-19
por: Al-Heeti, Omar, et al.
Publicado: (2022) -
Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions
por: Shih, Richard D., et al.
Publicado: (2020) -
Thinking forward: promising but unproven ideas for future intensive care
por: Marini, John J., et al.
Publicado: (2019) -
Mental health during the coronavirus disease 2019 (Covid-19) pandemic: more is still to be done
por: Endomba, Francky Teddy, et al.
Publicado: (2020) -
Remdesivir and Mortality in Patients With Coronavirus Disease 2019
por: Diaz, George A, et al.
Publicado: (2021)